The overlapping colors in the logo represent the synergy created by LPIXEL’s core technologies, which are the in the life sciences and image analysis. The innovative solutions created by the unison of the two core technologies are symbolic of the company’s efforts to spread new values to society.
The logo, characterized by its bold, original type face, represents LPIXEL’s unwavering will to resolve what the company feels are the society’s biggest problems. The logo is also representative of LPIXEL’s attitude to value reliability as a company, despite being a startup.
2014.3
LPIXEL is established by three members of a research laboratory at the University of Tokyo
2017.10
Selected as a “2017 Red Herring Top 100 Asia” winner by Red Herring magazine
2017.11
Development of EIRL, LPIXEL’s medical imaging diagnostic support Al, is announced and debuted at the Radiological Society of North America (RSNA) Annual Meeting 2017
2018.6
Awarded J-Startup status (A startup support initiative for globally competitive startups) by the Ministry of Economy, Trade and Industry
2019.10
After almost 3 years of development, the first product in the EIRL series — EIRL Brain Aneurysm — obtains regulatory approval and becomes one of Japan’s first deep learning-powered diagnostic support SaMDs
2020.6
Awarded special prize in the IT Japan Award 2020 by Nikkei Computer
2020.11
IMACEL business renewed, with increased specialization in pharmaceutical R&D support
2020.12
The number of healthcare facilities adopting EIRL series products for clinical use exceeds 100.
2021.3
EN ISO 13485 certification obtained
2022.7
EIRL Cloud launched – medical imaging diagnostic support Al now available from anywhere.
2024.6
The number of medical facilities using EIRL series products surpasses 800